Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS
Abstract
Background: Pathologic changes in the motor cortex and corticospinal tracts in ALS may be reflected by abnormal signal intensities on conventional MRI. The sensitivity of these changes in detecting underlying pathology remains unclear.
Method: The authors used automated image analysis to quantify volumes of cerebral gray and white matter in 16 patients with ALS (eight limb onset, eight bulbar onset) and eight normal controls. Previously they had demonstrated a reduction in N-acetyl aspartate/creatine + phosphocreatine (NAA/[Cr + PCr]) measured by 1H-MRS in the subcortical white matter in the motor cortex region in the patients with bulbar-onset ALS. To determine whether this resulted from axonal degeneration, they also compared gray and white matter volumes in the patients with limb- and bulbar-onset ALS.
Results: There were no differences in the total brain volumes of gray or white matter for the three subject groups (p > 0.23). Comparison of the total ALS group and controls revealed localized deficits in gray matter volume centered on Brodmann areas 8, 9, and 10 bilaterally. Comparison of the patients with limb- and bulbar-onset ALS revealed deficits in the white matter volume in the bulbar-onset group, extending bilaterally from the precentral gyrus into the internal capsule and brainstem, consistent with the course of the corticospinal tract. There was no loss in gray matter volume in the precentral gyri.
Conclusions: The loss of gray matter in the frontal regions (total ALS group) provides further support that ALS is a multisystem disorder. In addition, there is in vivo evidence of axonal degeneration in the subcortical white matter in the motor region in patients with bulbar-onset ALS. This is consistent with a “dying back” process affecting cortical motoneurons in bulbar-onset ALS.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Goodin DS, Rowley HA, Olney RK. Magnetic resonance imaging in amyotrophic lateral sclerosis. Ann Neurol . 1988; 23: 418–420.
2.
Horiuchi M, Sugihara H, Fujisawa K, Abe M, Tadokoro M. [An autopsy case of amyotrophic lateral screlosis (ALS): magnetic resonance imaging and pathological findings of the pyramidal tract] [Japanese]. Rinsho Shinkeigaku . 1997; 37: 810–816.
3.
Abe K, Fujimura H, Kobayashi Y, Fujita N, Yanagihara T. Degeneration of the pyramidal tracts in patients with amyotrophic lateral sclerosis. A premortem and postmortem magnetic resonance imaging study. J Neuroimaging . 1997; 7: 208–212.
4.
Hajnal JV, De Coene B, Lewis PD, et al. High signal regions in normal white matter shown by heavily T2-weighted CSF nulled IR sequences. J Comput Assist Tomogr . 1992; 16: 506–513.
5.
Thorpe JW, Moseley IF, Hawkes CH, MacManus DG, McDonald DG, Miller DH. Brain and spinal cord MRI in motor neuron disease. J Neurol Neurosurg Psychiatry . 1996; 61: 314–317.
6.
Segawa F. [MR findings of the pyramidal tract in amyotrophic lateral sclerosis] [Japanese]. Rinsho Shinkeigaku . 1993; 33: 835–844.
7.
Waragai M. MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology . 1997; 39: 847–851.
8.
Imon Y, Yamaguchi S, Yamamura Y, et al. [The effect of age and disease on the MR imaging T2 low signal intensity area in the cerebral cortex] [Japanese]. Nippon Ronen Igakkai Zasshi . 1994; 31: 697–704.
9.
Kushner PD, Stephenson DT, Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain [see comments]. J Neuropathol Exp Neurol . 1991; 50: 263–277.
10.
Pellissier JF, Baeta AM, Figarella–Branger D. Neuropathology of the cortex in amyotrophic lateral sclerosis with dementia. Adv Neurol . 1995; 68: 139–4.
11.
Kato S, Hayashi H, Yagishita A. Involvement of the frontotemporal lobe and limbic system in amyotrophic lateral sclerosis: as assessed by serial computed tomography and magnetic resonance imaging. J Neurol Sci . 1993; 116: 52–58.
12.
Kiernan JA, Hudson AJ. Frontal lobe atrophy in motor neuron diseases. Brain . 1994; 117 (pt 4): 747–757.
13.
Abrahams S, Leigh PN, Harvey A, Vythelingum GN, Grise D, Goldstein LH. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia. 2000; 38: 734–47.
14.
Ludolph AC, Langen KJ, Regard M, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand . 1992; 85: 81–89.
15.
Suckling J, Brammer MJ, Lingford–Hughes A, Bullmore ET. Removal of extracerebral tissues in dual-echo magnetic resonance images via linear scale-space features. Magn Reson Imaging . 1999; 17: 247–256.
16.
Suckling J, Sigmundsson T, Greenwood K, Bullmore ET. A modified fuzzy clustering algorithm for operator independent brain tissue classification of dual echo MR images. Magn Reson Imaging . 1999; 17: 1065–1076.
17.
Bullmore ET, Suckling J, Overmeyer S, Rabe–Hesketh S, Taylor E, Brammer MJ. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging . 1999; 18: 32–42.
18.
Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology . 1994; 44: 1933–1938.
19.
Chan S, Shungu DC, Douglas–Akinwande A, Lange DJ, Rowland LP. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology . 1999; 212: 763–769.
20.
Block W, Karitzsky J, Traber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease. Arch Neurol . 1998; 55: 931–936.
21.
Rooney W, Miller RD, Gelinas D, Schuff N, Maudsley AA, Weiner MW. Decreased N-acetyl aspartate in motor cortex and corticospinal tract in ALS. Neurology . 1998; 50: 1800–1805.
22.
Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, Werdelin M. Quantification of brain metabolites in amyotrophic lateral sclerosis by localised proton magnetic resonance spectroscopy. Neurology . 1997; 48: 878–881.
23.
Bowen BC, Pattany PM, Bradley WG, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol . 2000; 21: 647–658.
24.
Bradley WG, Bowen BC, Pattany PM, Rotta F. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci . 1999; 169: 84–86.
25.
Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SCR, Leigh PN. A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology . 1998; 51: 1104–1109.
26.
Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci . 1994; 124 (suppl): 96–107.
27.
Simmons A, Arridge SR, Barker GJ, Williams SCR. Simulation of MRI cluster plots and application to neurological segmentation. Magn Reson Imaging . 1996; 14: 73–92.
28.
Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry . 1998; 172: 527–532.
29.
Talairach J, Tournoux P. A coplanar stereotactic atlas of the human brain. Stuttgart: Thieme Verlag, 1988.
30.
Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res . 1996; 29: 162–173.
31.
Charcot JM, Joffroy A. Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux anterolateraux de la moelle epiniere. Arch Physiol Neurol Pathol . 1999; 2: 744–760.
32.
Waragai M, Shinotoh H, Hayashi M, Hattori T. High signal intensity on T1 weighted MRI of the anterolateral column of the spinal cord in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry . 1997; 62: 88–91.
33.
Waragai M, Takaya Y, Hayashi M. Serial MRI and SPECT in amyotrophic lateral sclerosis: a case report. J Neurol Sci . 1997; 148: 117–120.
34.
Cheung G, Gawel MJ, Cooper PW, Farb RI, Ang LC. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Neurology . 1995; 194: 263–270.
35.
Oba H, Araki T, Ohtomo K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Neurology . 1993; 189: 843–846.
36.
Gredal O, Pakkenberg H, Karlsborg M, Pakkenberg B. Unchanged total number of neurons in motor cortex and neocortex in amyotrophic lateral sclerosis: a stereological study. J Neurosci Methods . 2000; 95: 171–176.
37.
Kiernan JA, Hudson AJ. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain . 1991; 114 (pt 2): 843–853.
38.
Kew JJ, Goldstein LH, Leigh PN, et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study. Brain . 1993; 116 (pt 6): 1399–1423.
39.
Kew JJ, Brooks DJ, Passingham RE, Rothwell JC, Frackowiak RS, Leigh PN. Cortical function in progressive lower motor neuron disorders and amyotrophic lateral sclerosis: a comparative PET study. Neurology . 1994; 44: 1101–1110.
40.
Kew JJ, Leigh PN, Playford ED, et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain . 1993; 116 (pt 3): 655–680.
41.
Abrahams S, Goldstein LH, Kew JJ, et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain . 1996; 119 (pt 6): 2105–2120.
42.
Hirano A, Kurland LT, Sayre GP. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol . 1967; 16: 232–243.
43.
Nakano I, Hirano A, Kurland LT, Mulder DW, Holley PW, Saccamanno G. Familial amyotrophic lateral sclerosis. Neuropathology of two brothers in American C family. Neurol Med (Tokyo) . 1984; 20: 458–471.
44.
Tanaka J, Nakamura H, Tabuchi Y, Takahashi K. Familial amyotrophic lateral sclerosis: features of multisystem degeneration. Acta Neuropathol . 1984; 64: 22–29.
45.
Takahashi H, Oyanagi K, Ikuta F, Tanaka M, Yuasa T, Miyatake T. Widespread multiple system degeneration in a patient with familial amyotrophic lateral sclerosis. J Neurol Sci . 1993; 120: 15–21.
46.
Mizutani T, Sakamaki S, Tsuchiya N, et al. Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol . 1992; 84: 372–377.
47.
Sasaki S, Tsutsumi Y, Yamane K, Sakuma H, Maruyama S. Sporadic amyotrophic lateral sclerosis with extensive neurological involvement. Acta Neuropathol . 1992; 84: 211–215.
48.
Lloyd CM, Richardson MP, Brooks DJ, Al-Chalabi A, Leigh PN. Extramotor involvement in ALS: PET studies with the GABAA ligand 11C-flumazenil. Brain . 2000; 123: 2289–2296.
Information & Authors
Information
Published In
Copyright
© 2001.
Publication History
Received: November 27, 2000
Accepted: July 2, 2001
Published online: November 13, 2001
Published in print: November 13, 2001
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Graph theory network analysis reveals widespread white matter damage in brains of patients with classic ALS, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, (1-8), (2024).https://doi.org/10.1080/21678421.2024.2410281
- Retinal Disorders in Humans and Experimental ALS Models, Animal Models and Experimental Research in Medicine, (2023).https://doi.org/10.5772/intechopen.107052
- Neuroimaging findings in preclinical amyotrophic lateral sclerosis models—How well do they mimic the clinical phenotype? A systematic review, Frontiers in Veterinary Science, 10, (2023).https://doi.org/10.3389/fvets.2023.1135282
- An Understanding of Different Mechanisms Leading to Neurodegenerative Diseases, Handbook of Neurodegenerative Disorders, (1-53), (2023).https://doi.org/10.1007/978-981-19-3949-5_10-1
- Structural magnetic resonance imaging findings and histopathological correlations in motor neuron diseases—A systematic review and meta-analysis, Frontiers in Neurology, 13, (2022).https://doi.org/10.3389/fneur.2022.947347
- Optical coherence tomography in neurodegenerative disorders, Arquivos de Neuro-Psiquiatria, 80, 2, (180-191), (2022).https://doi.org/10.1590/0004-282x-anp-2021-0134
- Corticospinal Tract and Related Grey Matter Morphometric Shape Analysis in ALS Phenotypes: A Fractal Dimension Study, Brain Sciences, 11, 3, (371), (2021).https://doi.org/10.3390/brainsci11030371
- Case Report: Cognitive Conversion in a Non-brazilian VAPB Mutation Carrier (ALS8), Frontiers in Neurology, 12, (2021).https://doi.org/10.3389/fneur.2021.668772
- Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis, Brain, 143, 12, (3603-3618), (2021).https://doi.org/10.1093/brain/awaa340
- Amiotrophic Lateral Sclerosis, Hybrid PET/MR Neuroimaging, (397-410), (2021).https://doi.org/10.1007/978-3-030-82367-2_34
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.